Rutgers Cancer Institute of New Jersey: A Consensus View - Proton Therapy for Breast Cancer
September 22, 2021
September 22, 2021
NEW BRUNSWICK, New Jersey, Sept. 22 (TNSJou) -- Rutgers Cancer Institute of New Jersey issued the following news:
Bruce Haffty, MD, MS, chair of Radiation Oncology and associate vice chancellor for Cancer Programs at Rutgers Cancer Institute of New Jersey and system director of Radiation Oncology at RWJBarnabas Health, treated a breast cancer patient with proton therapy which is a unique type of radiation treatment that can precisely target and deliver high radiation doses to a tumo . . .
Bruce Haffty, MD, MS, chair of Radiation Oncology and associate vice chancellor for Cancer Programs at Rutgers Cancer Institute of New Jersey and system director of Radiation Oncology at RWJBarnabas Health, treated a breast cancer patient with proton therapy which is a unique type of radiation treatment that can precisely target and deliver high radiation doses to a tumo . . .